English | 简体中文 | 繁體中文 | 한국어 | 日本語
  Press Releases
Wednesday, August 3, 2022
Zhaoke Ophthalmology Completed Patient Enrollments for the Phase III Clinical Trials of the Myopia Progression Treatment Drug NVK002
Monday, November 15, 2021
兆科眼科获选于2021年美国眼科学会年会Eyecelerator@AAO上发表演讲
兆科眼科獲選於2021年美國眼科學會年會Eyecelerator@AAO上發表演講
Monday, May 24, 2021
兆科眼科(6622.HK)两项产品通过国家药监局药品注册现场核查及GMP符合性检查
兆科眼科(6622.HK)兩項產品通過國家藥監局藥品註冊現場核查及GMP符合性檢查
Two Products of Zhaoke Ophthalmology (6622.HK) Passes On-Site Inspection for Drug Registration by National Medical Products Administration and GMP Compliance Inspection by Guangdong Medical Products Administration

Copyright © 2022 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575